Positron emission tomography: Brain tumors and lung cancer

Rosalie J Hagge, T. Z. Wong, R. E. Coleman

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


F-18 fluorodeoxyglucose positron emission tomography is a uniquely powerful diagnostic tool that noninvasively provides information that is critical to appropriate clinical management of patients with non-small cell lung cancer. Not only does the functional information provided by PET complement and clarify the anatomic information supplied by CT and MR imaging, but the superior sensitivity and negative predicted value of PET allow for improved accuracy in diagnosis, prognosis, staging, and monitoring the effects of treatment. With better information at their disposal, clinicians and patients are able to make better-informed decisions, contributing to more appropriate amd more cost-effective medical care. Truly, FDG-PET has earned its place as the new standard of care in imaging non-small cell lung cancer.

Original languageEnglish (US)
Pages (from-to)871-881
Number of pages11
JournalRadiologic Clinics of North America
Issue number5
StatePublished - 2001
Externally publishedYes

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology


Dive into the research topics of 'Positron emission tomography: Brain tumors and lung cancer'. Together they form a unique fingerprint.

Cite this